Aurora Cannabis Receives Health Canada Licensing of Aurora Sky and MedReleaf Bradford

Published: February 26, 2019

Aurora Cannabis Receives Health Canada Licensing of Aurora Sky and MedReleaf Bradford

Aurora Cannabis Inc. announced that both its Aurora Sky and MedReleaf Bradford facilities are now fully licensed by Health Canada for the production and sale of cannabis and cannabis derivative products.

“The rapid scale-up of our production capacity – with our Sky and Bradford facilities specifically adding over 128,000 kg per year in capacity – is resulting in significant increases in product availability across our domestic medical and consumer, as well as our international market segments, over the coming months,” said Terry Booth, CEO of Aurora. “Current production at Aurora Sky, with recent harvests exceeding target yields, validates our production philosophy and our investment in high-tech, highly automated facilities. MedReleaf Bradford employs best practices identified during the integration of the Aurora and MedReleaf organizations, and is consistently delivering exceptional yields and high-quality product that has resonated well in both the medical and consumer markets.”